Jill Graham is a Scientist in the Genomic Medicine Unit at Sanofi, Genzyme focusing on the characterization of cell and gene therapy products by mass spectrometry. She attended the University of California, Santa Cruz for undergrad and received a BSc. in molecular, cellular and developmental biology. Prior to joining to Sanofi, Jill received her Ph. D from the University of Massachusetts, Amherst where she focused on cellular protein trafficking and post-translational modifications. Applying a background in cell biology and protein characterization, she now performs in-depth analytics of complex biomolecules for the development of innovative and long-lasting therapeutics in the GMU characterization group.